Clinical trial
Adjunctive Fosfomycin for Treatment of Staphylococcus Aureus Bacteraemia: Protocol for a Pooled Post-hoc Analysis of Two Randomised Clinical Trials
NCT06695832 is registered in ClinicalTrials.gov with Hospital Universitari de Bellvitge as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Adjunctive Fosfomycin for Treatment of Staphylococcus Aureus Bacteraemia: Protocol for a Pooled Post-hoc Analysis of Two Randomised Clinical Trials
- Lead sponsor
- Hospital Universitari de Bellvitge
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- November 1, 2024
- Completion date
- January 31, 2025
- Enrollment
- 369 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
staphylococcus aureus bacteremia